Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Hepatology2017Vol. 67(1), pp. 123–133
Citations Over TimeTop 1% of 2017 papers
Abstract
With continued high rates of adult obesity and DM along with an aging population, NAFLD-related liver disease and mortality will increase in the United States. Strategies to slow the growth of NAFLD cases and therapeutic options are necessary to mitigate disease burden. (Hepatology 2018;67:123-133).
Related Papers
- → Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease(2018)69 cited
- → Nonalcoholic fatty liver disease and liver transplantation(2006)140 cited
- → Fatty Liver Disease Prediction Using Supervised Learning(2021)1 cited
- → Advances in the application of model for end-stage liver disease and MELD-Na scores in liver transplantation(2019)
- → Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease(2023)